Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2012 17:21 ET | Source: BioSyent Inc.

BioSyent Releases Second Quarter Results; Record Quarterly Sales and Profit: Sales Up 89%, Profit Up 196%

TORONTO, ONTARIO--(Marketwire - Aug. 22, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Second Quarter (Q2) 2012 financial results. ...
August 16, 2012 17:33 ET | Source: BioSyent Inc.

BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For Two New Drug Products

TORONTO, ONTARIO--(Marketwire - Aug. 16, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive...
July 25, 2012 16:21 ET | Source: BioSyent Inc.

BioSyent Announces: Health Canada Approves New FeraMAX(R) Powder-Water Soluble Polysaccharide-Iron Complex

TORONTO, ONTARIO--(Marketwire - July 25, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has received marketing approval from...
June 19, 2012 20:02 ET | Source: BioSyent Inc.

BioSyent Pharma Secures Two Long-Term Hospital Supply Contracts for Cathejell(TM) Jelly 2%-Shipments Commence

TORONTO, ONTARIO--(Marketwire - June 19, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has secured two long-term hospital...
May 22, 2012 17:30 ET | Source: BioSyent Inc.

BioSyent Releases First Quarter Results-Sales Increase 89%, Net Income Sets All-Time Quarterly Record

TORONTO, ONTARIO--(Marketwire - May 22, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its First Quarter (Q1) 2012 financial results. ...
May 09, 2012 16:43 ET | Source: BioSyent Inc.

BioSyent Pharma Launches Cathejell(TM) Jelly 2%; Shipments to Commence May 2012

TORONTO, ONTARIO--(Marketwire - May 9, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has launched Cathejell™...
March 29, 2012 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Fiscal 2011 and Fourth Quarter Financial Results-Strong Growth Continues

TORONTO, ONTARIO--(Marketwire - March 29, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Fiscal 2011 and Fourth Quarter (Q4) 2011 financial results. ...
February 15, 2012 18:28 ET | Source: BioSyent Inc.

BioSyent Named to the TSX Venture Top 50(R) Ranking

MISSISSAUGA, ONTARIO--(Marketwire - Feb. 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announced today that it has been named as one of the 2012 TSX Venture Top 50 companies. ...
December 15, 2011 17:48 ET | Source: BioSyent Inc.

BioSyent Announces Appointment of New Director

MISSISSAUGA, ONTARIO--(Marketwire - Dec. 15, 2011) - The Board of Directors of BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce the appointment of Paul R. Montador to...
November 15, 2011 16:00 ET | Source: BioSyent Inc.

BioSyent Releases Third Quarter 2011 Financial Results-Pharma Sales More Than Triple; YTD Sales Growth 73%

MISSISSAUGA, ONTARIO--(Marketwire - Nov. 15, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2011 financial results. Total...